Filter By Category
Archives
Share on -
AMELOMETASONE
Generic Name: AMELOMETASONE
ABSTRACT -
Amelometasone (TS-410) is a synthetic glucocorticoid corticosteroid related to betamethasone/mometasone-type topical steroid chemistry. It was investigated for anti-inflammatory corticosteroid activity but was not marketed as a standard medicinal product. Its expected pharmacology is glucocorticoid receptor activation with reduction of local inflammatory mediators and immune-cell activation.
This document is for structured API information only. It is not a prescribing guide. Clinical use, if any, must follow the approved local label, trial protocol, and specialist medical supervision.
DOSAGE -
Dosage should be determined only by a qualified healthcare professional.
- No approved dosing regimen is available because amelometasone is not a marketed standard medicine.
- Any investigational use would require a controlled protocol specifying formulation, route, strength, and duration.
- Avoid substitution with approved corticosteroids without clinician review because potency and exposure may differ.
SIDE EFFECTS–
Possible side effects and safety concerns include:
- Local burning, itching, dryness, or irritation
- Acne, folliculitis, perioral dermatitis, or contact dermatitis
- Skin atrophy, striae, telangiectasia, or pigment changes with prolonged topical steroid exposure
- Secondary infection or delayed wound healing
- Systemic steroid effects such as adrenal suppression or hyperglycaemia if absorbed in significant amounts
ALLRGIC REACTIONS–
Hypersensitivity to Amelometasone or related compounds/products may occur. Symptoms may include:
- Rash or contact dermatitis
- Urticaria
- Pruritus
- Facial or throat swelling
- Severe hypersensitivity symptoms
Important: Patients who develop an allergic reaction to Amelometasone should seek immediate medical attention and inform all future healthcare providers of the allergy.
DRUG INTERACTIONS–
Amelometasone may interact with certain medicines, vaccines, protocols, or clinical conditions. Caution is needed with:
- Other corticosteroids may increase cumulative steroid exposure.
- CYP3A inhibitors may increase exposure if significant systemic absorption occurs.
- Immunosuppressants may increase infection risk.
- Live vaccines may be less effective or riskier with significant systemic corticosteroid exposure.
Patients should inform healthcare providers about all prescription medicines, over-the-counter medicines, herbal products, vaccines, and supplements they are using.
PREAUTIONS–
- Avoid prolonged use, occlusion, or application over large surface areas unless protocol-directed.
- Use caution on face, groin, intertriginous areas, and in children.
- Do not apply to untreated bacterial, fungal, or viral skin infection unless directed.
- Pregnancy and lactation safety are not established.
WARNINGS –
- Amelometasone is not an approved marketed corticosteroid.
- Excessive corticosteroid exposure can cause skin atrophy, ocular complications, hyperglycaemia, and adrenal suppression.
- Do not use in or near the eye unless specifically directed by a specialist.
- Keep out of reach of children.
Share on -
. Developed by